Skip to content

The American Society for Preventive Cardiology

JOIN        LOGIN        CONTACT

The American Society for Preventive Cardiology

  • Join ASPC
  • Login
  • Contact Us
aspc-logo-219
  • About Us
    • History
    • Board of Directors
    • Executive Team
    • Advocacy Statements
    • Corporate Partners
    • Collaborations
    • Awards
    • News
    • Frequently Asked Questions
    • Contact Us
  • Clinical Resources
    • Tools for Patients
      • INTERVENT
      • FH Insurance Guide
      • Prep for a Telehealth Visit
      • FH Fact Sheet
      • Navigating Open Enrollment for People Living with CVD
      • U.S. Apheresis Treatment Centers
    • Tools for Clinicians
      • American Journal of Preventive Cardiology
      • ASPC Clinical Practice Statements
      • DocMatter Login
      • Guidelines
      • Infographics
      • Articles & Publications
      • Scientific Statements
      • COVID-19 Resources
      • ASPC Mobile App
      • PCSK9 Inhibitor Access
      • Educational Presentations
      • Podcasts
      • Nonstatin PA Checklist
      • Coverage for Nutrition Services
    • Videos
      • COVID-19 and the Heart: 5 Things You Should Know
      • Continuity of Care in Patients with/at High Risk for CVD During the COVID-19 Pandemic
      • Emory Cardiovascular Risk Reduction in Young Adults webinar series
      • Doing Well by Doing Good: The Business of CV Prevention
      • ASPC Update on the 2019 ACC/AHA Prevention Guidelines Webinar
      • ASPC Update on the New 2018 Cholesterol Guidelines Webinar
      • PCSK9 Inhibitors: Access Barriers Affect Real People
      • Accessing Breakthrough Cholesterol Treatments
  • Membership
    • Manage Account
    • Join ASPC
    • Member Benefits
    • ASPC Working and Interest Groups
    • DocMatter Login
  • Professional Development
    • 2023 Congress
    • 2023 PCEC
    • 2023 Imaging MasterClass
    • Events Center
    • Online CME
    • Expert Lectures
    • Fellow of the ASPC
    • ASPC Manual of Preventive Cardiology
  • Careers
    • Job Board
    • Resources
  • Journal
  • About Us
    • History
    • Board of Directors
    • Executive Team
    • Advocacy Statements
    • Corporate Partners
    • Collaborations
    • Awards
    • News
    • Frequently Asked Questions
    • Contact Us
  • Clinical Resources
    • Tools for Patients
      • INTERVENT
      • FH Insurance Guide
      • Prep for a Telehealth Visit
      • FH Fact Sheet
      • Navigating Open Enrollment for People Living with CVD
      • U.S. Apheresis Treatment Centers
    • Tools for Clinicians
      • American Journal of Preventive Cardiology
      • ASPC Clinical Practice Statements
      • DocMatter Login
      • Guidelines
      • Infographics
      • Articles & Publications
      • Scientific Statements
      • COVID-19 Resources
      • ASPC Mobile App
      • PCSK9 Inhibitor Access
      • Educational Presentations
      • Podcasts
      • Nonstatin PA Checklist
      • Coverage for Nutrition Services
    • Videos
      • COVID-19 and the Heart: 5 Things You Should Know
      • Continuity of Care in Patients with/at High Risk for CVD During the COVID-19 Pandemic
      • Emory Cardiovascular Risk Reduction in Young Adults webinar series
      • Doing Well by Doing Good: The Business of CV Prevention
      • ASPC Update on the 2019 ACC/AHA Prevention Guidelines Webinar
      • ASPC Update on the New 2018 Cholesterol Guidelines Webinar
      • PCSK9 Inhibitors: Access Barriers Affect Real People
      • Accessing Breakthrough Cholesterol Treatments
  • Membership
    • Manage Account
    • Join ASPC
    • Member Benefits
    • ASPC Working and Interest Groups
    • DocMatter Login
  • Professional Development
    • 2023 Congress
    • 2023 PCEC
    • 2023 Imaging MasterClass
    • Events Center
    • Online CME
    • Expert Lectures
    • Fellow of the ASPC
    • ASPC Manual of Preventive Cardiology
  • Careers
    • Job Board
    • Resources
  • Journal
Search
Close

Industry News: FDA Approves New Drug for the treatment of patients with HoFH

By ASPC | February 12, 2021

View the Press Release

Posted in ASPC News
JOIN ASPC
LOGIN

Contact

The American Society for Preventive Cardiology
450-106 SR 13 N, #140
Jacksonville, FL 32259-3863

Phone: (904) 217-7407
Email: contact@aspconline.org

  • Home
  • About Us
  • Membership
  • News
  • Contact Us
  • DocMatter Login
  • Intervent

Latest News

ASPC and NLA publish joint clinical perspective on the importance of low-density lipoprotein cholesterol measurement and control as performance measures

Despite the established role of low-density lipoprotein cholesterol (LDL-C) as a major…

Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL® (bempedoic acid) Meets Primary Endpoint

Esperion (NASDAQ: ESPR) today announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regimen…

Bayer’s KERENDIA® (finerenone) Receives Updated Label to Include Findings From Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients With Chronic Kidney Disease and Type 2 Diabetes

Bayer announced today that it received approval from the United States (U.S.)…

Connect with us

SUBSCRIBE NOW

Get notified with latest updates, press releases, webinars and more!

ASPC MC Subscribe

© 2019 The American Society for Preventive Cardiology. All Rights Reserved. Privacy Policy

Scroll To Top